Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
After institutional review board approval, our prospectively-maintained clinical database was queried for men who underwent a RP at Memorial Sloan Kettering Cancer Center (MSKCC) between 2006–2012 as the primary treatment for prostate cancer and who had at least one high-risk criteria as defined by the NCCN: PSA 20 ng/mL or higher, clinical stage T3 or greater, or preoperative Gleason score 8–10.14 Patients were excluded if they had undergone previous radiotherapy or ADT.
Copyright and License information: ©2016
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
